tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Danielle Brill, 45 are a HOLD (16.36%), 225 are a BUY (81.82%), 5 are a SELL (1.82%).
Analyst Danielle Brill, currently employed at TRUIST, carries an average stock price target met ratio of 58.81% that have a potential upside of 36.04% achieved within 232 days.
Danielle Brill’s has documented 506 price targets and ratings displayed on 35 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ALNY, Alnylam Pharmaceuticals at 13-Jul-2026.
Analyst best performing recommendations are on AGIO (AGIOS PHARM).
The best stock recommendation documented was for AGIO (AGIOS PHARM) at 10/31/2024. The price target of $51 was fulfilled within 6 days with a profit of $6.57 (14.79%) receiving and performance score of 24.65.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 17-Apr-2025
$36
$10.13 (39.16%)
$26
Hold Since 20-Jun-2022
$25
$-0.87 (-3.36%)
$24
Buy Since 23-Jun-2025
$36
$10.13 (39.16%)
$30
Buy Since 30-Jun-2026
$30
$4.13 (15.96%)
$29
Buy Since 21-Oct-2025
$35
$9.13 (35.29%)
$32
Which stock is Danielle Brill is most bullish on?
Which stock is Danielle Brill is most reserved on?
What Year was the first public recommendation made by Danielle Brill?
